Factors of emotional distress in lymphoma: A systematic review.
cancer
distress
lymphoma
oncology
risk factors
survivorship
Journal
Cancer medicine
ISSN: 2045-7634
Titre abrégé: Cancer Med
Pays: United States
ID NLM: 101595310
Informations de publication
Date de publication:
07 2023
07 2023
Historique:
revised:
24
04
2023
received:
15
03
2023
accepted:
30
04
2023
medline:
21
7
2023
pubmed:
18
5
2023
entrez:
18
5
2023
Statut:
ppublish
Résumé
Distress is prevalent among lymphoma patients/survivors. Current processes of distress identification rely on self-reporting by patients/survivors, which may be limited by their willingness to report symptoms. To help identify patients/survivors at greater risk, this systematic review aims to comprehensively review factors that may contribute to distress in lymphoma patients/survivors. PubMed was systematically searched for peer-reviewed primary articles (1997-2022) consisting of standardised keywords "lymphoma" and "distress." Information from 41 articles was integrated via narrative synthesis. Consistent risk factors of distress include younger age, relapsed disease, and greater comorbidities and symptom burden. Active treatment and the transition from treatment to post-treatment could be challenging phases. Adequate social support, adaptive adjustment to cancer, engaging in work and healthcare professionals' support may mitigate distress. There is some evidence that older age may be associated with greater depression and life changes/experiences may shape how individuals cope with lymphoma. Gender and marital status were not robust predictors of distress. Other clinical, psychological and socioeconomic factors are understudied or have mixed findings. While several factors of distress align with that of other cancers, more research is needed to identify significant factors of distress in lymphoma patients/survivors. The identified factors may support clinicians in identifying distressed lymphoma patients/survivors and providing interventions where necessary. The review also highlights avenues for future research and a need to routinely collect data on distress and its factors in registries.
Identifiants
pubmed: 37199079
doi: 10.1002/cam4.6069
pmc: PMC10358206
doi:
Types de publication
Systematic Review
Journal Article
Review
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
14646-14662Informations de copyright
© 2023 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.
Références
J Psychosoc Oncol. 2015;33(2):124-41
pubmed: 25581206
Health Psychol. 2020 Jul;39(7):580-588
pubmed: 32212767
Semin Oncol Nurs. 2021 Apr;37(2):151142
pubmed: 33773881
Eur J Haematol. 2014 Sep;93(3):229-38
pubmed: 24702126
Patient Educ Couns. 2014 Feb;94(2):143-8
pubmed: 24169023
Eur J Oncol Nurs. 2019 Jun;40:53-62
pubmed: 31229207
BMC Cancer. 2015 Oct 24;15:781
pubmed: 26498342
J Psychosom Res. 2003 Apr;54(4):289-92
pubmed: 12670604
J Psychosoc Oncol. 2020 May-Jun;38(3):251-271
pubmed: 31617830
Oncol Nurs Forum. 2016 Sep 1;43(5):E195-E2014
pubmed: 27541562
Leukemia. 2022 Jul;36(7):1720-1748
pubmed: 35732829
J Health Psychol. 2018 Sep;23(11):1464-1475
pubmed: 27469009
J Adv Nurs. 2011 Nov;67(11):2363-72
pubmed: 21517940
Oncol Nurs Forum. 2010 Mar;37(2):E105-13
pubmed: 20189909
Support Care Cancer. 2021 Jun;29(6):3319-3328
pubmed: 33118105
Ann Oncol. 2008 Mar;19(3):570-6
pubmed: 18056649
J Clin Nurs. 2019 Feb;28(3-4):400-409
pubmed: 30178544
Psychooncology. 2018 Mar;27(3):791-801
pubmed: 29318702
Curr Med Res Opin. 2018 Aug;34(8):1529-1535
pubmed: 29741105
BMJ. 2021 Mar 29;372:n71
pubmed: 33782057
Ann Oncol. 2010 Nov;21(11):2262-2266
pubmed: 20423914
J Psychosoc Oncol. 2012;30(4):426-45
pubmed: 22747106
Psychooncology. 2013 May;22(5):978-86
pubmed: 22674873
Blood Rev. 2019 Jan;33:63-73
pubmed: 30093158
Oncol Nurs Forum. 2004 Sep 17;31(5):937-44
pubmed: 15378094
Ann Behav Med. 2007 Oct;34(2):188-99
pubmed: 17927557
Support Care Cancer. 2022 Mar;30(3):2387-2395
pubmed: 34761297
Clin J Oncol Nurs. 2019 Feb 1;23(1):43-51
pubmed: 30681995
Ann Behav Med. 2020 Dec 1;54(12):978-984
pubmed: 33416842
Psychol Health Med. 2019 Aug;24(7):781-787
pubmed: 30714815
Am J Hematol. 2022 Jun 1;97(6):749-761
pubmed: 35298039
Leuk Lymphoma. 2003 Nov;44(11):1925-9
pubmed: 14738144
Health Qual Life Outcomes. 2017 Sep 19;15(1):180
pubmed: 28927453
Br J Cancer. 1997;76(6):791-6
pubmed: 9310248
Eur J Oncol Nurs. 2020 Feb;44:101693
pubmed: 31783326
Support Care Cancer. 2019 Jul;27(7):2453-2462
pubmed: 30377801
Acta Psychiatr Scand. 1983 Jun;67(6):361-70
pubmed: 6880820
J Cancer Surviv. 2015 Sep;9(3):481-91
pubmed: 25603948
Acta Oncol. 2014 Jul;53(7):917-26
pubmed: 24456497
Psychooncology. 2013 Jun;22(6):1208-19
pubmed: 22888070
Front Oncol. 2018 Jun 04;8:163
pubmed: 29915719
Eur J Oncol Nurs. 2017 Jun;28:62-68
pubmed: 28478857
J Adolesc Young Adult Oncol. 2020 Aug;9(4):540-545
pubmed: 32255694
PLoS One. 2017 Nov 6;12(11):e0187673
pubmed: 29107959
Psychooncology. 2013 Jul;22(7):1581-6
pubmed: 22936310
Leuk Lymphoma. 2021 Jun;62(6):1370-1378
pubmed: 34082646
Global Health. 2021 Jul 28;17(1):87
pubmed: 34321015
Oncol Nurs Forum. 2013 Jul;40(4):349-60
pubmed: 23803268
Support Care Cancer. 2013 Aug;21(8):2153-9
pubmed: 23475196
Psychooncology. 2010 Dec;19(12):1259-67
pubmed: 20099255
J Adv Nurs. 2018 Nov;74(11):2622-2629
pubmed: 29989199
Cancer Med. 2023 Jul;12(13):14646-14662
pubmed: 37199079
Ann Hematol. 2011 Sep;90(9):993-1004
pubmed: 21670973
Leuk Lymphoma. 2010 Apr;51(4):628-40
pubmed: 20218810
Eur J Cancer Care (Engl). 2005 Mar;14(1):7-15
pubmed: 15698382
Psychooncology. 2015 Jun;24(6):712-7
pubmed: 25099337
Psychooncology. 2008 Nov;17(11):1061-72
pubmed: 18561287
J Adv Pract Oncol. 2019 Mar;10(2):175-179
pubmed: 31538028
Cancer Nurs. 2020 Jul/Aug;43(4):E229-E238
pubmed: 31045591
Cancer Nurs. 2021 Nov-Dec 01;44(6):489-498
pubmed: 32604137
Psychooncology. 2009 Jul;18(7):767-74
pubmed: 19061200
Psychooncology. 2013 Feb;22(2):241-9
pubmed: 22287503
J Natl Cancer Inst. 2015 Feb 24;107(4):
pubmed: 25717170
Int J Evid Based Healthc. 2015 Sep;13(3):179-87
pubmed: 26262565
J Clin Oncol. 2012 Apr 10;30(11):1160-77
pubmed: 22412146
J Clin Oncol. 2008 Feb 20;26(6):934-41
pubmed: 18281667
J Cancer Surviv. 2023 Jun;17(3):769-780
pubmed: 35982359
Cancer. 2015 Sep 15;121(18):3343-51
pubmed: 26036473
Br J Psychiatry. 1994 Nov;165(5):593-8
pubmed: 7866674
Eur J Cancer. 2013 May;49(8):1948-56
pubmed: 23465493
J Clin Oncol. 2009 Sep 10;27(26):4346-51
pubmed: 19652074
Cancer. 2014 Mar 1;120(5):633-41
pubmed: 24895287
Psychooncology. 2014 May;23(5):481-92
pubmed: 24375630
Transl Oncol. 2022 Feb;16:101328
pubmed: 34990907
Psychooncology. 2013 Feb;22(2):434-40
pubmed: 22162210
Curr Oncol Rep. 2015;17(5):447
pubmed: 25824699
Health Qual Life Outcomes. 2016 Jul 29;14(1):114
pubmed: 27473596
Cancer. 2019 Nov 15;125(22):4096-4104
pubmed: 31355929
J Health Psychol. 2016 Oct;21(10):2357-66
pubmed: 25845834
Health Psychol. 2001 Jan;20(1):71-5
pubmed: 11199068
Oncol Nurs Forum. 2013 Mar;40(2):157-62
pubmed: 23448740
J Natl Compr Canc Netw. 2019 Oct 1;17(10):1229-1249
pubmed: 31590149
Cancer Med. 2020 Jun;9(12):4395-4404
pubmed: 32301251
BMC Cancer. 2019 Oct 11;19(1):943
pubmed: 31604468
J Cancer Surviv. 2014 Dec;8(4):555-64
pubmed: 24820429
Ann Hematol. 2003 Jan;82(1):14-8
pubmed: 12574958
Cancer Nurs. 2009 Nov-Dec;32(6):E1-17; quiz E18-9
pubmed: 19816166
Integr Cancer Ther. 2013 May;12(3):225-35
pubmed: 22791309